Skip to main content
. 2020 Jan 16;12(1):70. doi: 10.3390/pharmaceutics12010070

Table 3.

Cytotoxicity of HAPs and HAP-Ps on the cell viability (%) of HCT116 spheroids.

Concentration (µg/mL) HAP HAP-P
48 h
12 ** 90.16 ±6.9 110.7 ±5.0
37 ** 96.09 ±14.8 117.05 ±1.3
111 ** 78.29 ±9.6 107.56 ± 12.0
333 ** 88.18 ±6.4 91.74 ±7.0
1000 ** 78.69 ±6.9 88.58 ±5.0
72 h
12 129.2 ±12.7 129.2 ±9.7
37 122.1 ±17.2 122.1 ±19.0
111 130.8 ±15.6 130.8 ±14.0
333 125.7 ±11.4 125.7 ±11.6
1000 120.7 ±6.7 120.7 ±4.3

** Significant difference (p = 0.0049) between concentrations at 48 h. No significant difference was observed between HAP and HAP-P at 48 or 72 h.